Prestige Consumer Healthcare Inc.

NYSE:PBH Stock Report

Market Cap: US$3.8b

Prestige Consumer Healthcare Management

Management criteria checks 4/4

Prestige Consumer Healthcare's CEO is Ron Lombardi, appointed in Jun 2015, has a tenure of 9.67 years. total yearly compensation is $5.76M, comprised of 17.4% salary and 82.6% bonuses, including company stock and options. directly owns 0.59% of the company’s shares, worth $22.16M. The average tenure of the management team and the board of directors is 8.3 years and 4.8 years respectively.

Key information

Ron Lombardi

Chief executive officer

US$5.8m

Total compensation

CEO salary percentage17.4%
CEO tenure9.7yrs
CEO ownership0.6%
Management average tenure8.3yrs
Board average tenure4.8yrs

Recent management updates

Recent updates

Here's Why Prestige Consumer Healthcare (NYSE:PBH) Can Manage Its Debt Responsibly

Feb 07
Here's Why Prestige Consumer Healthcare (NYSE:PBH) Can Manage Its Debt Responsibly

Pinning Down Prestige Consumer Healthcare Inc.'s (NYSE:PBH) P/S Is Difficult Right Now

Jan 16
Pinning Down Prestige Consumer Healthcare Inc.'s (NYSE:PBH) P/S Is Difficult Right Now

Prestige Consumer Healthcare Inc. (NYSE:PBH) Shares Could Be 45% Below Their Intrinsic Value Estimate

Dec 04
Prestige Consumer Healthcare Inc. (NYSE:PBH) Shares Could Be 45% Below Their Intrinsic Value Estimate

We Think Prestige Consumer Healthcare (NYSE:PBH) Can Stay On Top Of Its Debt

Nov 03
We Think Prestige Consumer Healthcare (NYSE:PBH) Can Stay On Top Of Its Debt

Prestige Consumer Healthcare Inc.'s (NYSE:PBH) Popularity With Investors Is Under Threat From Overpricing

Sep 10
Prestige Consumer Healthcare Inc.'s (NYSE:PBH) Popularity With Investors Is Under Threat From Overpricing

Prestige Consumer Healthcare (NYSE:PBH) Seems To Use Debt Quite Sensibly

Jul 16
Prestige Consumer Healthcare (NYSE:PBH) Seems To Use Debt Quite Sensibly

Revenues Not Telling The Story For Prestige Consumer Healthcare Inc. (NYSE:PBH)

May 22
Revenues Not Telling The Story For Prestige Consumer Healthcare Inc. (NYSE:PBH)

Here's Why Prestige Consumer Healthcare (NYSE:PBH) Can Manage Its Debt Responsibly

Mar 26
Here's Why Prestige Consumer Healthcare (NYSE:PBH) Can Manage Its Debt Responsibly

An Intrinsic Calculation For Prestige Consumer Healthcare Inc. (NYSE:PBH) Suggests It's 50% Undervalued

Mar 05
An Intrinsic Calculation For Prestige Consumer Healthcare Inc. (NYSE:PBH) Suggests It's 50% Undervalued

Prestige Consumer Healthcare Inc. (NYSE:PBH) Just Released Its Third-Quarter Results And Analysts Are Updating Their Estimates

Feb 11
Prestige Consumer Healthcare Inc. (NYSE:PBH) Just Released Its Third-Quarter Results And Analysts Are Updating Their Estimates

Prestige Consumer Healthcare Inc.'s (NYSE:PBH) Shares May Have Run Too Fast Too Soon

Feb 05
Prestige Consumer Healthcare Inc.'s (NYSE:PBH) Shares May Have Run Too Fast Too Soon

Here's Why Prestige Consumer Healthcare (NYSE:PBH) Can Manage Its Debt Responsibly

Dec 14
Here's Why Prestige Consumer Healthcare (NYSE:PBH) Can Manage Its Debt Responsibly

Prestige Consumer Healthcare (NYSE:PBH) Seems To Use Debt Quite Sensibly

Sep 10
Prestige Consumer Healthcare (NYSE:PBH) Seems To Use Debt Quite Sensibly

Prestige Consumer Healthcare: Unproductive Buyback And Excessive Valuation

Aug 15

Is Prestige Consumer Healthcare (NYSE:PBH) Using Too Much Debt?

Jun 12
Is Prestige Consumer Healthcare (NYSE:PBH) Using Too Much Debt?

An Intrinsic Calculation For Prestige Consumer Healthcare Inc. (NYSE:PBH) Suggests It's 43% Undervalued

May 20
An Intrinsic Calculation For Prestige Consumer Healthcare Inc. (NYSE:PBH) Suggests It's 43% Undervalued

Here's Why Prestige Consumer Healthcare (NYSE:PBH) Has Caught The Eye Of Investors

Mar 17
Here's Why Prestige Consumer Healthcare (NYSE:PBH) Has Caught The Eye Of Investors

Here's Why Prestige Consumer Healthcare (NYSE:PBH) Can Manage Its Debt Responsibly

Mar 02
Here's Why Prestige Consumer Healthcare (NYSE:PBH) Can Manage Its Debt Responsibly

Prestige Consumer Healthcare Inc.'s (NYSE:PBH) Intrinsic Value Is Potentially 75% Above Its Share Price

Feb 08
Prestige Consumer Healthcare Inc.'s (NYSE:PBH) Intrinsic Value Is Potentially 75% Above Its Share Price

Prestige Consumer Healthcare reports Q3 earnings beat; updates FY23 guidance

Feb 02

Prestige Consumer Healthcare: Taking My Winnings Off The Table

Jan 19

Here's Why Prestige Consumer Healthcare (NYSE:PBH) Can Manage Its Debt Responsibly

Nov 23
Here's Why Prestige Consumer Healthcare (NYSE:PBH) Can Manage Its Debt Responsibly

Prestige Consumer Healthcare GAAP EPS of $1.02 beats by $0.02, revenue of $289.3M beats by $6.07M

Nov 03

Holding Prestige Consumer Healthcare

Aug 31

If EPS Growth Is Important To You, Prestige Consumer Healthcare (NYSE:PBH) Presents An Opportunity

Aug 26
If EPS Growth Is Important To You, Prestige Consumer Healthcare (NYSE:PBH) Presents An Opportunity

We Think Prestige Consumer Healthcare (NYSE:PBH) Can Stay On Top Of Its Debt

Aug 05
We Think Prestige Consumer Healthcare (NYSE:PBH) Can Stay On Top Of Its Debt

Prestige Consumer Healthcare GAAP EPS of $1.09 beats by $0.05, revenue of $277.1M beats by $8.18M

Aug 04

Should You Be Adding Prestige Consumer Healthcare (NYSE:PBH) To Your Watchlist Today?

May 27
Should You Be Adding Prestige Consumer Healthcare (NYSE:PBH) To Your Watchlist Today?

Is Prestige Consumer Healthcare (NYSE:PBH) A Risky Investment?

May 05
Is Prestige Consumer Healthcare (NYSE:PBH) A Risky Investment?

Does Prestige Consumer Healthcare (NYSE:PBH) Deserve A Spot On Your Watchlist?

Feb 22
Does Prestige Consumer Healthcare (NYSE:PBH) Deserve A Spot On Your Watchlist?

Is Prestige Consumer Healthcare (NYSE:PBH) A Risky Investment?

Feb 03
Is Prestige Consumer Healthcare (NYSE:PBH) A Risky Investment?

These 4 Measures Indicate That Prestige Consumer Healthcare (NYSE:PBH) Is Using Debt Extensively

Nov 04
These 4 Measures Indicate That Prestige Consumer Healthcare (NYSE:PBH) Is Using Debt Extensively

CEO Compensation Analysis

How has Ron Lombardi's remuneration changed compared to Prestige Consumer Healthcare's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2024n/an/a

US$214m

Sep 30 2024n/an/a

US$206m

Jun 30 2024n/an/a

US$205m

Mar 31 2024US$6mUS$1m

US$209m

Dec 31 2023n/an/a

-US$81m

Sep 30 2023n/an/a

-US$82m

Jun 30 2023n/an/a

-US$84m

Mar 31 2023US$6mUS$1m

-US$82m

Dec 31 2022n/an/a

US$210m

Sep 30 2022n/an/a

US$209m

Jun 30 2022n/an/a

US$203m

Mar 31 2022US$6mUS$937k

US$205m

Dec 31 2021n/an/a

US$189m

Sep 30 2021n/an/a

US$179m

Jun 30 2021n/an/a

US$179m

Mar 31 2021US$5mUS$888k

US$165m

Dec 31 2020n/an/a

US$166m

Sep 30 2020n/an/a

US$163m

Jun 30 2020n/an/a

US$152m

Mar 31 2020US$5mUS$875k

US$142m

Dec 31 2019n/an/a

-US$34m

Sep 30 2019n/an/a

-US$34m

Jun 30 2019n/an/a

-US$36m

Mar 31 2019US$4mUS$850k

-US$36m

Dec 31 2018n/an/a

US$64m

Sep 30 2018n/an/a

US$340m

Jun 30 2018n/an/a

US$340m

Mar 31 2018US$4mUS$850k

US$340m

Compensation vs Market: Ron's total compensation ($USD5.76M) is about average for companies of similar size in the US market ($USD6.61M).

Compensation vs Earnings: Ron's compensation has been consistent with company performance over the past year.


CEO

Ron Lombardi (60 yo)

9.7yrs

Tenure

US$5,763,133

Compensation

Mr. Ronald M. Lombardi, also known as Ron, served as a Director at Consumer Healthcare Products Association. He has been the Chief Executive Officer and President of Prestige Brands Holdings, Inc. (now Pre...


Leadership Team

NamePositionTenureCompensationOwnership
Ronald Lombardi
Chairman9.7yrsUS$5.76m0.59%
$ 22.2m
Christine Sacco
CFO & COO8.4yrsUS$2.00m0.036%
$ 1.3m
William P'Pool
Senior VP8.3yrsUS$1.34m0.026%
$ 989.2k
Adel Mekhail
Executive Vice President of Marketing & Sales5.8yrsUS$1.32m0.024%
$ 920.8k
Jeffrey Zerillo
Senior Vice President of Operationsno dataUS$862.93k0.064%
$ 2.4m
Philip Terpolilli
Director of Investor Relationsno datano datano data
Dean Siegal
Director of Communicationsno datano datano data
Mary Fritz
Senior Vice President of Quality & Regulatory Affairs6.7yrsno data0.030%
$ 1.1m

8.3yrs

Average Tenure

60yo

Average Age

Experienced Management: PBH's management team is seasoned and experienced (8.3 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Ronald Lombardi
Chairman9.7yrsUS$5.76m0.59%
$ 22.2m
John Byom
Lead Independent Director19.1yrsUS$273.33k0.097%
$ 3.7m
Clesteen Clark
Independent Director4yrsUS$257.08k0.014%
$ 528.2k
Dawn Zier
Independent Director4.8yrsUS$260.63k0.020%
$ 756.5k
Sheila Hopkins
Independent Director9.5yrsUS$243.33k0.048%
$ 1.8m
James D'Arecca
Independent Director1.5yrsUS$197.92kno data
John Kelly
Independent Directorless than a yearno datano data

4.8yrs

Average Tenure

63yo

Average Age

Experienced Board: PBH's board of directors are considered experienced (4.8 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/06 08:39
End of Day Share Price 2025/02/06 00:00
Earnings2024/12/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Prestige Consumer Healthcare Inc. is covered by 16 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Olivia Tong CheangBofA Global Research
Linda Bolton-WeiserB. Riley Securities, Inc.
Susan AndersonCanaccord Genuity